Jaya Krishnan | Co-founder
Genome Biologics

Professor Jaya Krishnan has had a successful career spanning 
over two decades in cardiovascular research and biotechnology 
entrepreneurship. He obtained his PhD in biochemistry with a 
specialization in molecular oncology at the Forschungszentrum 
Karlsruhe (now the Karlsruhe Institute of Technology) and the Imperial 
College London in 2003. Inspired by personal circumstances, he 
transitioned his research focus to heart disease and completed 
his postdoctoral research at the Institute of Cell Biology, ETH-Zürich, 
Switzerland (2004–2009), establishing expertise in cardiovascular 
biology and metabolism. This led to an assistant professor position 
at the Institute of Molecular Health Sciences, ETH-Zürich (2009–2012), 
focusing on cardiovascular disease metabolism. Professor Krishan 
then joined Imperial College London as a Senior Lecturer (2012–2015), 
coinciding with his role as a Group Head at the Medical Research 
Council. In his current role as a Professor of Molecular Cardiology at 
Goethe-Universität Frankfurt a. Main, Professor Krishnan leads the RNA 
Therapeutics research group. He also co-founded Genome Biologics, 
a biotechnology company specializing in state-of-the-art 3D human 
cardiac disease models for cardiovascular and cardiometabolic 
drug development and validation, and Cardiogen Therapeutics, a 
company involved in the clinical development of cardiac regenerative 
therapies. His experience in both academia and industry positions 
him as a key player in the modern scientist–entrepreneur model.